The cellular uptake of vitamin A from its RBP4-bound circulating form (holo-RBP4) is a homeostatic process that evidently depends on the multidomain membrane protein STRA6. In humans, mutations in STRA6 are associated with Matthew-Wood syndrome, manifested by multisystem developmental malformations. Here we addressed the metabolic basis of this inherited disease. STRA6-dependent transfer of retinol from RBP4 into cultured NIH 3T3 fibroblasts was enhanced by lecithin:retinol acyltransferase (LRAT). The retinol transfer was bidirectional, strongly suggesting that STRA6 acts as a retinol channel/transporter. Loss-of-function analysis in zebrafish embryos revealed that Stra6 deficiency caused vitamin A deprivation of the developing eyes. We provide evidence that, in the absence of Stra6, holo-Rbp4 provokes nonspecific vitamin A excess in several embryonic tissues, impairing retinoic acid receptor signaling and gene regulation. These fatal consequences of Stra6 deficiency, including craniofacial and cardiac defects and microphthalmia, were largely alleviated by reducing embryonic Rbp4 levels by morpholino oligonucleotide or pharmacological treatments.
INTRODUCTION
The biological importance of retinoids (vitamin A and its derivatives) for vertebrate development has long been known, because both deprivation of and excessive exposure to retinoids cause major embryonic abnormalities (reviewed by Mark et al., 2006) . Vitamin A is the precursor of at least two critical metabolites: 11-cis-retinal, the chromophore of visual G protein-coupled receptors (Palczewski, 2006) , and all-trans-retinoic acid (RA). RA regulates gene expression via heterodimeric nuclear receptors consisting of both RA receptors (RARs) and retinoid X receptors (RXRs) (Giguere et al., 1987; Petkovich et al., 1987) . Both are ligand-dependent transcription factors belonging to the superfamily of nuclear hormone receptors (Chambon, 1996) .
A prerequisite for initiation of retinoid-dependent physiological processes is the coordinated production of biologically active retinoids from circulating precursors. To achieve this, cells and tissues must be adequately supplied with this vitamin throughout their life cycle. All-trans-retinol bound to the retinol-binding protein RBP4 (holo-RBP4) serves as the major transport mode for vitamin A in the blood (Blomhoff et al., 1990) . It has long been postulated that cellular retinol uptake from holo-RBP4 is a facilitated, protein-mediated process (for review, see Blaner, 2007) . Recently, it has been suggested that the multitransmembrane domain protein STRA6 acts as the long-sought RBP4 receptor. In cell cultures, STRA6 specifically binds to holo-RBP4 and mediates the cellular uptake of retinol (Kawaguchi et al., 2007) . In mammals, STRA6 is expressed in a variety of embryonic and adult cells and tissues (Bouillet et al., 1997; Kawaguchi et al., 2007) . Mutations of STRA6 in humans cause the fatal Matthew-Wood syndrome, characterized by pleiotropic, multisystem malformations that include cardiac deformities and ocular defects (Golzio et al., 2007; Pasutto et al., 2007) . These dramatic consequences of STRA6 deficiency were unexpected because RBP4-deficient patients display only a mild clinical phenotype that includes night blindness and modest retinal dystrophy (Biesalski et al., 1999) . RBP4-deficient mice also are phenotypically normal except for a visual impairment early in life that can be corrected during adolescence by maintaining them on a vitamin A-rich diet (Quadro et al., 1999) . The discrepancy between the STRA6-and RBP4-deficient phenotypes led to the speculation that STRA6 functions in an additional unknown process (Blaner, 2007) . To address this question, we further characterized the function of STRA6 in cell culture and established a zebrafish model to elucidate the biochemical and developmental consequences of STRA6 deficiency.
RESULTS

STRA6 Enhances Retinol Uptake in NIH 3T3 Cells
To confirm that STRA6 mediates the cellular uptake of vitamin A, we established stable NIH 3T3 cell lines expressing human STRA6 and human lecithin:retinol acyltransferase (LRAT). To obtain a cell line expressing both proteins, we introduced a human STRA6 gene construct into NIH 3T3 cells expressing human LRAT. Expression of STRA6 was confirmed by immunoblotting and immunohistochemistry. ID4-tagged STRA6 localized to the plasma membrane and, to some extent, to the endoplasmic reticulum as shown by the merged image with calreticulin ( Figure 1A ). To determine STRA6-mediated retinol uptake from holo-RBP4, we incubated the different cell lines with 8 mM holo-RBP4 for 16 hr and then analyzed their retinoid content by high-pressure liquid chromatography (HPLC). The chromatograms revealed that retinol uptake from holo-RBP4 was dramatically enhanced in cells expressing both STRA6 and LRAT as compared to cells expressing only STRA6 ( Figure 1B) . The observation that neither retinyl esters (RE) nor all-trans-retinol were detected in STRA6-expressing cells indicated a key role of LRAT for efficient retinol uptake into target cells. To quantify differences in retinol uptake, we determined the kinetics of this process by incubating STRA6/LRAT-and LRAT-expressing cells with holo-RBP4. This experiment revealed an up to 8-fold higher retinol uptake by cells expressing both STRA6 and LRAT ( Figure 1C ). The uptake and esterification of retinol followed hyperbolic kinetics and reached saturation after 25 hr of incubation.
STRA6 Mediates Bidirectional Transport of Retinol
We next addressed the question of whether STRA6 also mediates the release of retinol from cells by adding all-trans-retinol (10 mM) to the culture medium to preload STRA6/LRAT-and LRAT-expressing cells with RE. Both cell lines produced comparable amounts of RE upon incubation with all-trans-retinol (see Figure S1 available online). Cells then were washed with PBS buffer to remove all-trans-retinol. Subsequently, fresh medium containing 8 mM of apo-RBP4 was added. After 16 hr incubation, we analyzed the retinoid composition of the medium by HPLC. Indeed, the quantity of all-trans-retinol was greatly increased in (D) STRA6-dependent release of retinol. Cells were incubated with 10 mM all-trans-retinol for 16 hr prior to this experiment. Cells then were washed with PBS, and fresh medium containing 8 mM apo-RBP4 was added. After 16 hr, the medium was collected and retinoid composition was determined by HPLC. Values represent the mean ± SD of three independent experiments. (E) Retinoic acid uptake is not STRA6 dependent. Apo-RBP was loaded with all-trans-retinoic acid (RA) and purified by fast protein liquid chromatography (FPLC). Efficiency of RA loading was confirmed by absorption spectroscopy (inset). NIH 3T3 cells stably expressing STRA6 and LRAT were incubated with 8 mM RA-RBP4 or 8 mM RA overnight. Retinoid composition was determined by reverse-phase chromatography.
the medium of cells expressing both STRA6 and LRAT as compared to that of cells expressing LRAT alone ( Figure 1D ). Thus, STRA6 appears to function as a channel or transporter that mediates bidirectional transport of retinol in partnership with RBP4.
Uptake of RA Is Not STRA6 Dependent Because STRA6 deficiency causes multisystem developmental malformations of various organs, STRA6 has been suggested to play a role in the uptake of RA, the biologically active vitamin A derivative during development (Golzio et al., 2007) . To test this hypothesis in the cell culture system, we loaded apo-RBP4 with RA and incubated the holo-RA-RBP4 complex with cells expressing STRA6 and LRAT for 16 hr. Even though we found RA bound to RBP4 ( Figure 1E , inset), RA did not accumulate in STRA6/LRAT-expressing cells. In contrast, RA not bound to RBP4 was efficiently taken up by these cells ( Figure 1E ), and various RA stereoisomers became detectable in these cells. Thus, we found no evidence in cell culture that STRA6 can mediate RA uptake from a holo-RA-RBP4 complex.
Expression of rbp4 and stra6 in Zebrafish Development We next used the zebrafish to analyze Stra6 function in an animal model. An rbp4 homologous gene was recently identified in this teleost (Tingaud-Sequeira et al., 2006) , and a putative zebrafish stra6 homologous gene has also been reported in the Ensembl database (www.ensembl.org/Danio_rerio/index.html). Both rbp4 and stra6 genes appear to be present as single copies in the zebrafish (www.ensembl.org/Danio_rerio/index.html). We cloned the corresponding cDNAs by RT-PCR and verified their sequences after full-length cloning. The predicted amino acid sequences of zebrafish Stra6 and Rbp4 shared an overall identity with their murine and human counterparts ( Figure S2 ). We then analyzed stra6 and rbp4 mRNA expression patterns with antisense RNA probes by whole-mount in situ hybridization (WISH) (Figure 2 ). Zebrafish rbp4 was expressed in the yolk syncytial layer, starting with segmentation stages and persisting in these cells as development proceeded (Figures 2F and 2G) . We also verified Rbp4 expression at the protein level by immunoblot analysis with an antiserum raised against human RBP4 ( Figure 2H ). Expression of stra6 was detectable in the yolk syncytium and in mesendodermal cells in the head and trunk region during early somitogenesis stages (Figure 2A ). At 24 hours postfertilization (hpf), expression of stra6 appeared to be maintained in some of these tissues, albeit at a decreased level (data not shown). Moreover, staining for stra6 mRNA became detectable in anterior somites (Figures 2A and 2B) , which have been shown to contribute to RA production for hindbrain development (Begemann et al., 2001 ). Additionally, stra6 was expressed in the eye anlage and the pineal gland at this embryonic stage (Figures 2A and 2B ). The pineal gland is a light-sensitive endocrine organ that requires vitamin A for the production of a pineal-specific rhodopsin (Ziv and Gothilf, 2006) . At later developmental stages, stra6 expression became restricted to the developing eyes and pineal gland ( Figures 2C and 2D ) and was not detectable in other tissues. Cross-sections through the eyes of 4 days postfertilization (dpf) larvae revealed that stra6 mRNA was expressed in the retinal pigment epithelium (RPE) ( Figure 2E ).
Stra6 Knockdown Causes Embryonic Malformations
We used an antisense morpholino oligonucleotide (MO) approach (Nasevicius and Ekker, 2000) to perform a Stra6 loss-of-function study. We designed two nonoverlapping MOs directed against the 5 0 region of the stra6 mRNA, covering bases À27 to À3 (MO1) and À1 to +24 (MO2). Additionally, we used a splice donor site MO (MO3) to delete exon 5 of the stra6 mRNA ( Figures 3A and 3B ). The deletion of this exon resulted in a frameshift in the coding region of the corresponding mRNA, thereby disrupting the C-terminal part of the encoded Stra6 protein. After injection of each of these MOs into fertilized oocytes, we determined microscopically whether Stra6 deficiency caused developmental abnormalities. Morphants injected with any of the three MOs developed microphthalmia, had a curved body axis, and showed heart edema ( Figure 3D ). This phenotype was uniformly present (98%) in MO1-and MO2-treated embryos but was less frequent ($20%) in MO3-treated embryos. RT-PCR analysis confirmed the deletion of exon 5 in the stra6 mRNA isolated from 2 dpf MO3-treated morphants with malformations, whereas some wild-type stra6 mRNA was still detectable in MO3 morphants without severe malformations ( Figure 3C ). To confirm Stra6 deficiency in morphants treated with MO1 and MO2, we determined ocular retinoid levels in 4 dpf larvae that should have developed functional photoreceptors at this stage (Easter and Nicola, 1996) . HPLC revealed that total head retinoid levels were significantly reduced in these morphants ( Figure 3E ). RE was the most abundant vitamin A derivative, consistent with the expression of eye-specific Lrat in the RPE at this developmental time point (Isken et al., 2007) . 11-cis-retinal, the chromophore of visual pigments, also was detectable but significantly reduced in MO1 and MO2 morphant larvae ( Figure 3E ). Thus, a targeted knockdown of Stra6 caused both vitamin A deficiency in larval eyes and severe embryonic malformations.
stra6 Morphants Develop Severe Embryonic Defects
We next analyzed malformations in Stra6-deficient embryos in further morphological detail. Cross-sections through the eyes of 4 dpf larvae confirmed microphthalmia but revealed distinct retinal cell layers with normal stratification (Figures 4A and 4B) . Furthermore, morphants displayed cardiac edema along with dysmorphic heart chambers ( Figures 4C-4E ). To better visualize pathological alterations of the heart, we injected MO2 into a fish strain that expresses enhanced green fluorescent protein (EGFP) under control of the fli1 promoter in all vasculature and the heart (Lawson and Weinstein, 2002) . Confocal imaging revealed that the morphants' hearts were not looped and that their atria were dilated like a balloon (Figures 4F and 4G) . In vivo observations indicated that cardiac contractions were still detectable in Stra6-deficient embryos (n = 100). However, in the morphants with the most severe cardiac edema ($30%) ( Figure 4E ), blood (D) Photographs of 3 dpf control and characteristic stra6 morphant larvae injected with MO1, MO2, and MO3, respectively. (E) Retinyl esters (RE) and 11-cis-retinal levels in the heads of 4 dpf MO1 and MO2 morphants as compared to control larvae. Values represent the mean ± SD of three independent experiments. *p < 0.005 versus control by Student's t test.
did not circulate and staining for hemoglobin revealed extravasated red blood cells in the head ( Figures 4H and 4I ). Since morphants also exhibited an altered morphology of the craniofacial skeleton, we stained cartilage with Alcian blue (Figures 4J  and 4K ). The first and second arches were malformed, and the branchial arches were absent ( Figure 4K ). Thus, Stra6-deficient zebrafish embryos develop multisystemic malformations similar to those described for humans suffering from Matthew-Wood syndrome (Golzio et al., 2007; Pasutto et al., 2007) .
Stra6 Deficiency Causes RA Excess in Several Embryonic Tissues
As evidenced by many studies, RA deficiency causes patterning defects of the neural tube, somites, heart, and eyes in both zebrafish and mice (Begemann et al., 2001; Grandel et al., 2002; Hamade et al., 2006; Keegan et al., 2005; Niederreither et al., 1999) . Thus, an explanation for the pleiotropic malformations in the morphants could be a role of Stra6 in acquiring yolk vitamin A needed for retinoid signaling. However, consistent with the initiation of stra6 mRNA expression at somitogenesis, we found normal patterning of the hindbrain and somites by double WISH staining for krox20/myoD markers in the morphants ( Figures 5A and 5B) . Analysis of pax6.1 as an eye marker revealed that the presumptive retina was slightly smaller than normal in 21-somite embryos ( Figures 5C and 5D ). However, there was no loss of ventral parts of the retina, a characteristic described for RA-deficient zebrafish embryos (Hyatt et al., 1996; Marsh-Armstrong et al., 1994) . We next analyzed cyp26a1 mRNA levels. This retinoid hydroxylase catabolizes RA to polar metabolites, and its mRNA levels are upregulated in an RA-dependent manner (Abu-Abed et al., 2001; Emoto et al., 2005) . In 23-somite embryos, we found no difference in cyp26a1 mRNA expression between morphants and controls ( Figures 5E and 5F ). At 31 hpf, cyp26a1 mRNA expression was reduced but not absent in the developing eyes of morphants (Figures 5G and 5H) . Interestingly, cyp26a1 expression outside of the eyes was enhanced, e.g., in the pericardial region (Figures 5G and 5H) and in caudal parts of MO2 morphant embryos ( Figures 5I and 5J) . Thus, targeted knockdown of Stra6 does not cause embryonic RA deficiency at early developmental stages but rather results in excess RA production in several tissues as development proceeds.
Embryonic Defects Are Alleviated by Reducing RBP4 Levels Based on the observation of elevated cyp26a1 mRNA expression in the morphants, we speculated that holo-Rbp4 in the absence of Stra6 might cause local nonspecific RA excess, e.g., in the developing heart. Thus, we tried to prevent developmental abnormalities by reducing Rbp4 levels pharmacologically with the tyrosinase inhibitor 1-phenyl-2-thiourea (PTU) as well as by blocking rbp4 mRNA translation with an rbp4-MO covering À6 to +19 of the rbp4 mRNA. PTU inhibits pigmentation in zebrafish and also has been shown to downregulate rbp4 mRNA (H and I) Control (H) and 2 dpf MO2-treated (I) embryos with the heart phenotype shown in (E) stained for hemoglobin. In controls, staining for erythrocytes was primarily detectable in the heart and afferent vessels over the yolk. In morphants, hemoglobin was greatly reduced in the heart and afferent vessels, but red blood cell extravasations were visible in the head (see arrows).
(J and K) Alcian blue staining of cartilage of the craniofacial skeleton of 5 dpf control (J) and MO2-treated morphant (K) larvae. The Meckel's cartilage (m), palatoquadrates (pq), and ceratohyales (ch) were deformed and staining of ceratobranchials (asterisks) was highly reduced in Stra6 deficiency. Animals were raised in PTU-free water. Anterior is to the left in all pictures. Scale bars = 100 mm in (A)-(E) and (H)-(K).
expression at larval stages (Tingaud-Sequeira et al., 2006) . To confirm that PTU reduces Rbp4 levels during embryonic development, we performed WISH and immunoblot analyses. Both rbp4 mRNA expression and Rbp4 protein levels were decreased in the presence of 200 mM PTU in 24 hpf control and MO2 morphant embryos ( Figures 6A and 6C ). We also confirmed the reduction of Rbp4 levels by immunoblot analysis in rbp4-MO-treated embryos ( Figure 6C ). To show that reduced embryonic Rbp4 levels led to a diminished mobilization of yolk vitamin A, we determined retinoid levels of 4 dpf larvae. When animals were raised in the presence of PTU, retinoid content was significantly reduced in the larval eyes but significantly increased in the trunk ( Figure 6B ). Similarly, rbp4 morphants showed significantly reduced levels of retinoids in the eyes and significantly increased retinoid levels in the trunk ( Figure 6B ). Importantly, both PTU and rbp4-MO treatments caused no obvious developmental abnormalities ( Figures 6D and 6E ), such as microphthalmia and cardiac defects, as we had found in Stra6-deficient embryos.
To determine whether a reduction of Rbp4 levels could prevent developmental abnormalities in MO2 morphants, we microscopically analyzed morphant larvae raised in the presence and absence of this compound (n = 170 for each condition). When MO2 and PTU treatments were combined, visible developmental malformations were prevented in 73% of morphants ( Figure 6D ). In contrast, virtually all MO2-treated embryos raised in the absence of PTU showed cardiac edema and morphologically altered heart chambers ( Figure 6D ). Coinjection of both MO2 and rbp4-MO also prevented developmental impairment in 77% of the embryos, whereas all siblings injected with only MO2 developed the characteristic abnormalities ( Figure 6E ). Thus, reduction of embryonic Rbp4 levels either by pharmacological treatment via PTU or by rbp4-MO treatment can reduce the high fatality observed in Stra6-deficient zebrafish embryos.
DISCUSSION
Vitamin A is required throughout the vertebrate life cycle, e.g., for vision and cell proliferation and differentiation. All-trans-retinolbound RBP4 (holo-RBP4) is the most abundant retinoid derivative present in the circulation of humans and most vertebrates. In humans, inherited blood retinol deficiency has been described in a family with compound heterozygous missense mutations in RBP4. Two affected subjects had reduced visual acuity, night blindness, and mild ocular fundus atrophy (Biesalski et al., 1999) . Consistent with these defects, RBP4-deficient mice appear phenotypically normal except for a visual impairment early in life (Quadro et al., 1999) . Thus, it is generally accepted that RBP4 is required to maintain ocular vitamin A-dependent processes of vision but is not essential for embryonic RA production. Recently, STRA6 has been suggested to act as a holo-RBP4 receptor that facilitates uptake of vitamin A into target tissues (Kawaguchi et al., 2007) . Hence, it was surprising that STRA6 deficiency causes human Matthew-Wood syndrome with multisystem malformations related to impaired RA signaling (Golzio et al., 2007; Pasutto et al., 2007) . This finding conflicts with the proposed role of STRA6 as the long-sought holo-RBP4 receptor and suggests an additional unknown role for this membrane protein.
STRA6-Dependent Vitamin A Uptake Depends on LRAT
To address the biochemical basis of STRA6 deficiency, we established both a cell culture and an animal model. We cloned 
. Comparison of Marker Gene Expression between Control and stra6 Morphant Embryos
Marker genes and developmental stages of the embryos shown are indicated. Control embryo is shown at the left; stra6 morphant embryo is shown at the right. Animals were raised in PTU-free water. (A and B) Double staining for krox20 and myoD reveals normal patterning of the hindbrain rhombomeres and somites. Additionally, the distance between rhombomere 5 (R5) and the first somite (1 s) is comparable between control and morphant embryos. (C and D) Staining for pax6.1 (blue) at the 21-somite stage shows that the presumptive retina is smaller in stra6 morphants than in controls but that patterns of pax6.1 mRNA expression are comparable along the anteroposterior axis. (E-J) Staining for cyp26a1 mRNA expression. (E and F) cyp26a1 mRNA expression was indistinguishable between controls and MO2 morphants at the 23-somite stage. (G-J) cyp26a1 mRNA expression was reduced in the developing eye of MO2-treated morphants as compared to controls (arrow in [G] ), but deeper staining appeared in the pericardial region (arrowheads in [H] ) and in caudal parts of the morphant embryo (J) as compared to the control (I). Scale bars = 100 mm. Anterior is to the left in all pictures. zebrafish rbp4 and stra6 genes and showed that their expression was initiated at segmentation stages, shortly before functional circulation developed. At later larval stages, stra6 mRNA expression was restricted to the RPE of the eyes, indicating that the organism acquires vitamin A from holo-Rbp4 to support vision. Indeed, targeted knockdown of Stra6 caused biochemically detectable vitamin A deficiency of the larval eyes, thereby verifying the proposed function of STRA6 as a retinoid channel/transporter in an in vivo animal model.
Our cell culture studies revealed that only those cells expressing both STRA6 and LRAT accumulated significant amounts of vitamin A. Our finding that cells expressing STRA6 lacked retinoids suggests the existence of an intracellular, low-abundance acceptor for vitamin A. We provide several lines of evidence that LRAT acts as this acceptor. In cell culture, the flow of vitamin A between extra-and intracellular compartments is driven by metabolic conversion via LRAT toward cellular accumulation of RE. This idea is further supported by our findings in the zebrafish model. Both Lrat and Stra6 are expressed in the RPE, and RE accumulates in developing zebrafish eyes. Furthermore, lrat expression, like that of stra6, is already initiated early in development in the pineal gland at 24 hpf and in the eyes at 56 hpf ( Figure 2B ; Isken et al., 2007) . This requirement of LRAT for STRA6-dependent vitamin A accumulation also is manifest in a mammalian model: Lrat null mice are selectively vitamin A deficient in the eyes and liver (Batten et al., 2004) . Thus, we propose that RBP4, STRA6, and LRAT act sequentially in vitamin A uptake by target tissues. The fact that mammals including humans produce RE in various tissues, e.g., the liver, lung, and eyes, may provide an explanation for the more widespread expression of STRA6 and LRAT in mammals (Batten et al., 2004; Kawaguchi et al., 2007) as compared to zebrafish (Figure 2 ; Isken et al., 2007) . Additionally, we found that the STRA6 retinoid channel transports retinol bidirectionally in an RBP4-dependent manner, most probably facilitating attainment of steady-state concentrations of vitamin A between intracellular and extracellular pools. Such a STRA6-dependent homeostatic regulation of retinoid levels between extra-and intracellular compartments may play a more important role in mammalian embryos needing a continuous maternal supply of vitamin A than in zebrafish embryos that rapidly consume yolk vitamin A to establish vision.
STRA6 Is Essential to Maintain Embryonic RA Homeostasis
Our cell culture analyses exclude a role for STRA6 in acquiring RA, the developmentally active form of vitamin A, as has been recently suggested by others (Golzio et al., 2007) . We found no evidence that RBP4-bound RA is accumulated by STRA6-expressing cells. This suggests high substrate specificity for STRA6 or a requirement for an intracellular RA-binding protein (D) stra6 morphants and controls were raised in the presence and absence of PTU (n = 170 each). Representative photographs of 3 dpf larvae are shown. PTU treatment prevented developmental abnormalities in 73% of the stra6 morphants. In the absence of PTU, all stra6 morphants displayed cardiac edema (asterisk). (E) Larvae raised from oocytes either injected with rbp4-MO or coinjected with rbp4-MO and MO2. These morphant larvae were raised in the absence of PTU. rbp4 morphant larvae showed no developmental abnormalities (n = 120). Coinjection of rbp4-MO and MO2 largely prevented developmental abnormalities in 77% of the compound morphants (n = 120). Scale bar = 100 mM in (A) and 500 mm in (D) and (E). Anterior is to the left in all pictures.
that interacts with STRA6. Our analyses of the zebrafish model revealed that Stra6 deficiency causes, in addition to retinoid deficiency of the eyes, developmental abnormalities that include ocular, cardiac, and craniofacial malformations as described for STRA6-deficient patients who suffer from Matthew-Wood syndrome (Golzio et al., 2007; Pasutto et al., 2007) . Microphthalmia can be related to RA deficiency (Marsh-Armstrong et al., 1994) , but in contrast to RA-deficient zebrafish embryos (Biehlmaier et al., 2005; Lampert et al., 2003) , there was normal overall stratification of the retinal layers in Stra6-deficient embryos. Additionally, we observed no loss of ventral parts of the retina as has been described in RA-deficient zebrafish embryos (Hyatt et al., 1996) . In zebrafish, RA-dependent patterning processes of the developing eyes depend largely on b-carotene as the RA precursor (Lampert et al., 2003) . Thus, this process does not essentially require retinol delivered by holo-Rbp4 for RA production. Consistent with the absence of severe developmental eye defects, b-carotene together with circulating RE also has been suggested to prevent ocular defects in RBP4 deficiency in mammals, including humans (Paik et al., 2004) . Importantly, RA is required for optic cup specification later in development in mammals (Molotkov et al., 2006) . Accordingly, lack of RA production in developing murine eyes does not cause severe microphthalmia (clinical anophthalmia) (Molotkov et al., 2006) as has been described for patients suffering from Matthew-Wood syndrome (Golzio et al., 2007; Pasutto et al., 2007) . Thus, as evidenced here for zebrafish, secondary effects, most probably RA excess in surrounding tissues, cause microphthalmia in Stra6 deficiency. Cardiac and craniofacial abnormalities in Stra6-deficient zebrafish embryos could be also ascribed to embryonic RA excess rather than RA deficiency. This outcome was suggested by marker gene analysis showing elevated cyp26a1 expression in the developing heart together with the absence of stra6 expression in this organ. Thus, we speculated that these developmental abnormalities are caused by circulating holo-Rbp4 that cannot be cleared from the circulation in Stra6 deficiency. To reduce embryonic Rbp4 levels, we used PTU, a substance that inhibits pigmentation but also reduces rbp4 expression (Figure 6 ; Tingaud-Sequeira et al., 2006) . Additionally, we designed an rbp4-MO to block rbp4 mRNA translation. Both treatments reduced Rbp4 protein levels and the mobilization of yolk vitamin A. More importantly, they largely prevented developmental abnormalities in the Stra6-deficient morphants. Thus, we conclude that in Stra6 deficiency, Rbp4-bound vitamin A, which is not cleared from the circulation, provokes developmental abnormalities. This finding can be well extrapolated to the mammalian situation and provides a ready explanation for the biochemical basis of the dramatically different consequences of RBP4 and STRA6 deficiency in patients.
In summary, our study validates and extends the work of Kawaguchi and colleagues (2007) . We show in an animal model that Stra6 is the long-sought holo-Rbp4 receptor. In cell culture, we demonstrate that the STRA6 retinoid channel transports retinol bidirectionally in an RBP4-dependent manner. In this process, the net flow of vitamin A between extra-and intracellular compartments is driven by metabolic conversion via LRAT to support RE production. Furthermore, we provide evidence that in Stra6 deficiency, Rbp4-bound vitamin A, which is not cleared from the circulation, leads to developmental abnormalities.
Dysfunctions of STRA6 and RBP4 are related to human diseases as diverse as Matthew-Wood syndrome (Pasutto et al., 2007) and type 2 diabetes (Yang et al., 2005) . Thus, the generality of our findings in cell culture and zebrafish as presented here requires further testing in mammalian models such as Stra6 mutant and Stra6/Rbp4 double-mutant mice.
EXPERIMENTAL PROCEDURES
Stable Transduction of the NIH 3T3 Cell Line Full-length human STRA6 and LRAT clones were purchased from the American Type Culture Collection. To construct retroviral expression vectors, STRA6 and LRAT cDNAs were amplified by PCR, and EcoRI and NotI sites were introduced at the ends of the coding sequence using the primers 5 0 -GCAGATGAATTCACC ATGTCGTCCCAGCCAGCAGG-3 0 and 5 0 -CGTCTAGCGGCCGCTCAGGGCT GGGCACCATTGG-3 0 for STRA6 and 5 0 -GAGGTGAATTCAGCTACTCAGGGA TGAAGAACCCCATGCTG-3 0 and 5 0 -ACTGACGCGGCCGCATGAAGTTAGCC AGCCATCCATAG-3 0 for LRAT. These constructs were cloned into pMXs-IG or pMXs-IP retroviral vectors provided by T. Kitamura (University of Tokyo) (Kitamura et al., 2003) . Inserts were sequenced and confirmed to be identical to STRA6 and LRAT reference sequences deposited in the Ensembl database (www.ensembl.org). Stable transfectants of NIH 3T3 fibroblasts were generated using standard methods.
Immunohistochemistry
For cellular STRA6 detection, STRA6 was tagged at its C terminus with a 15-amino acid epitope (SATASKTETSQVAPA) corresponding to the ROS targeting sequence found in the C terminus of mouse rhodopsin (1D4). The 1D4 sequence was introduced by PCR using the primer 5 0 -TTCTAGCGGCCGC TCAGGCAGGCGCCACCTGGCTGGTCTCTGTGGGCTGGGCACCATTGG-3 0 .
Localization of 1D4-tagged STRA6 was performed by fixing NIH 3T3 cells expressing STRA6-1D4 with 4% paraformaldehyde in PBS for 10 min. Cells were washed three times with PBST (PBS with 0.1% Triton X-100) and incubated in 1.5% normal goat serum in PBST for 15 min at room temperature to block nonspecific binding. Cells then were incubated sequentially with anti-1D4-tagged monoclonal antibody followed by rabbit anti-calreticulin polyclonal antibody. Cells were rinsed in PBST three times and stained with Cy5-conjugated goat anti-mouse IgG and Cy3-conjugated goat anti-rabbit IgG for detection of calreticulin. Cells were mounted in 2% 1,4-diazabicyclo[2,2,2] octane in 90% glycerol to retard photobleaching and imaged with a Leica TCS SP2 confocal/multiphoton microscope equipped with a titanium/sapphire laser (Chameleon-XR, Coherent, Inc.).
Expression and Purification of Human RBP4
Human RBP4 cDNA cloned into a pET3a expression vector was a kind gift from J.W. Kelly (The Scripps Research Institute). The procedure used for RBP4 expression in E. coli was based on previously published methodology with slight modifications (Xie et al., 1998) . Briefly, RBP4 was expressed in BL21 cells according to a standard protocol. These bacterial cells were harvested and lysed by osmotic shock (Burger et al., 1993) . Insoluble material was pelleted, washed three times with 20 mM Tris-HCl (pH 8.0), and solubilized in 7 M guanidine hydrochloride and 10 mM DTT. Buffer (25 mM Tris-HCl [pH 8.8]) was added to dilute the guanidine hydrochloride concentration to 5.0 M. After overnight incubation, insoluble material was removed by ultracentrifugation (120,000 3 g, 1 hr, 4 C), and the collected supernatant was used for the RBP4 refolding procedure. RBP4 was refolded by dropwise addition of solubilized material to a mixture containing 25 mM Tris-HCl (pH 8.8), 0.3 mM cystine, 3.0 mM cysteine, 1 mM EDTA, and 1 mM retinol delivered in ethanol at 4 C. The reaction was continued for 5 hr at 4 C with vigorous mixing. The precipitate was removed by ultracentrifugation (120,000 3 g, 1 hr, 4 C), and the supernatant was dialyzed against 10 mM Tris-HCl (pH 8.0) at 4 C overnight, filtered, and loaded on a DE53 ion exchange chromatography column. Refolded holo-RBP4 was eluted by a linear gradient of NaCl (0-300 mM) in 10 mM Tris-HCl (pH 8.0). Collected fractions were examined by SDS-PAGE and UV-visible spectroscopy. Fractions containing RBP4 with an absorbance ratio of 0.9 or higher at 280/330 nm were pooled together, concentrated to 6 mg/ml with a ten-tube Amicon Centriprep concentrator, and stored at À80 C.
Loading of RBP4 with RA All-trans-retinol was extracted from holo-RBP4 with diethyl ether as described previously (Cogan et al., 1976) . The efficiency of retinol release was monitored by recording spectra of both the aqueous and organic phases. A solution of apo-RBP4 (2 mg/ml) in 20 mM Tris-HCl (pH 8.0) was incubated with 1 mM RA delivered in ethanol in the presence of glycerol (10%) for 2 hr at 4 C. The sample was diluted with 20 mM Tris-HCl (pH 8.0), centrifuged, and repurified on a Uno Q ion exchange column (Bio-Rad). The presence of RBP4-bound RA was confirmed by its absorbance spectrum after purification by HPLC.
Retinoid Uptake Assays
Twenty hours prior to the experiment, NIH 3T3 cells expressing LRAT, STRA6, or STRA6/LRAT were cultured in six-well culture plates at a density of 1 3 10 6 cells per well. After growth medium removal, cells were washed with PBS, and serum-free medium containing holo-RBP4 was added. After incubation, cells were washed with PBS twice, harvested, and extracted with 1 volume of methanol followed by 2 volumes of hexane. The organic phase was collected, dried down in a SpeedVac, and redissolved in 250 ml of hexane, and the composition of retinoids was analyzed by normal-phase HPLC on a Hewlett Packard 1100 series HPLC system equipped with a diode array detector. Retinyl esters were separated using an Agilent SI column (4.6 3 250 mm, 5 mm) and a stepped gradient of ethyl acetate in hexane (0.5% for 15 min and 20% up to 30 min at flow rate of 1.4 ml/min). The extraction procedure and reverse-phase HPLC conditions used for RA were described previously (Moise et al., 2005) .
Retinol Release Assays
Prior to the experiment, cells expressing LRAT or STRA6/LRAT were incubated with 10 mM all-trans-retinol in growth medium for 16 hr. Cells were then washed with PBS, and fresh medium containing 8 mM apo-RBP4 was added. After 16 hr incubation, the medium was collected and retinoid composition was analyzed by HPLC under the conditions described above.
Cloning of Zebrafish stra6 and rbp4
We searched the Ensembl zebrafish database (www.ensembl.org/Danio_rerio/ index.html) and found a cDNA sequence (GenBank accession number BC076188) encoding a protein with high overall amino acid sequence identity to mouse and human STRA6. For cloning, we performed RT-PCR with whole RNA preparations from 3 dpf larvae and the oligonucleotide primers stra6-up 5 0 -ATGAGTGCTGAAACTGTGAATAACT-3 0 and stra6-down 5 0 -TCAGTTGCT GGCAGCGGCGCT-3 0 . stra6 cDNA was cloned into the vector pCRII-TOPO (Invitrogen) and verified by sequencing. Zebrafish rbp4 cDNA (GenBank accession number AJ236884) was obtained by RT-PCR using the primers rbp4-up 5 0 -ATGTTAAGGCTCTGTATAGCA-3 0 and rbp4-down 5 0 -TTAGGCAG CCTCACAGAAAC-3 0 .
Fish Maintenance and Strains
Zebrafish (strain AB/TL) were bred and maintained under standard conditions at 28.5 C (Westerfield, 1994) . For analyzing heart morphology, we used the TG(fli1:EGFP) Y1 strain (Lawson and Weinstein, 2002) . Morphological features were used to determine the stage of the embryos in hpf or dpf (Kimmel et al., 1995) . Embryos were raised in either the presence or the absence of 200 mM 1-phenyl-2-thiourea (PTU, Sigma-Aldrich) as indicated in the figure legends.
Immunoblotting Embryos (five per lane) were homogenized and subjected to SDS-PAGE. Immunoblot analysis was performed using monoclonal antibody raised against human RBP4 (ab8609, Abcam) at a 1:500 dilution. Immunoblots were developed with the ECL system (Amersham Bioscience).
WISH and Histology WISH was performed as described by Hauptmann and Gerster (1994) . stra6 was cloned into the vector pCRII-TOPO (Invitrogen), and an antisense RNA probe was synthesized with the T7 RNA polymerase. Additional RNA probes used for in situ hybridization experiments were cyp26a1 (Emoto et al., 2005) , krox20 (Oxtoby and Jowett, 1993) , myoD (Weinberg et al., 1996) , pax6.1 (Nornes et al., 1998) , and rbp4 (Tingaud-Sequeira et al., 2006). RNA probes were generated with the DIG RNA Labeling Kit (Roche Molecular Biochemicals) according to the manufacturer's protocol.
Histology of tissues and staining for cartilage was performed as described previously (Lampert et al., 2003) Morpholino Oligonucleotide Knockdown For targeted knockdown of Stra6 protein, the following morpholino oligonucleotides (Gene Tools, LLC) were used. For blocking stra6 mRNA translation, we designed MO1 5 0 -TGCCAACCTATACAGCAAACAGAAG-3 0 covering À27 to À3 and MO2 5 0 -GTTATTCACAGTTTCAGCACTCATG-3 0 covering À1 to +24 of the stra6 mRNA. Additionally, we used MO3 5 0 -TATCTATTGTAAGTTAT ACCTGTGG-3 0 directed against the splice donor site of exon 5 of the stra6 pre-mRNA. For blocking rbp4 mRNA translation, we designed rbp4-MO 5 0 -CT ATACAGAGCCTTAACATACTTCC-3 0 covering À6 to +19 of the rbp4 mRNA.
The MOs were dissolved in 0.33 Danieau's solution (13 Danieau's solution: 5 mM HEPES [pH 7.6] containing 58 mM NaCl, 0.7 mM KCl, 0.4 mM MgSO 4 , 0.6 mM Ca(NO 3 ) 2 ) to obtain a stock concentration of 1 mM (8.4 mg/ml). 8 ng MO1, 15 ng MO2, 20 ng MO3, or 20 ng rbp4-MO was routinely injected per oocyte. For coinjections, 15 ng MO2 and 10 ng rbp4-MO were used per oocyte. The injected volume was 3 nl. We used RT-PCR analysis to confirm deletion of exon 5. For this purpose, we isolated total RNA from 2 dpf morphant and control embryos (n = 20 each) with the RNeasy kit (QIAGEN) according to the manufacturer's protocol. Reverse transcription was carried out with 70 ng total RNA and SuperScript reverse transcriptase (Invitrogen). For PCR, we used Taq polymerase (Stratagene) and the primers MO3-up 5 0 -TTTAGACCACACGCAACACAA G-3 0 and MO3-down 5 0 -CTCAGAGGCATTGGCTGTCTC-3 0 .
HPLC Analysis of Retinoids in Zebrafish Larvae
Fish were raised in darkness prior to extraction of retinoids. To determine the retinoid content of 4 dpf larval eyes and trunks, we removed the anterior part of the head, including the eyes, by hand dissection with a scalpel. HPLC analysis was carried out as described previously (Isken et al., 2007) . For retinoid quantification, peak integrals were scaled with defined amounts of reference substances and quantified using 32 Karat software (Beckman Instruments). Student's t test was used for statistical analyses.
Photography
Photographs were taken of live embryos fixed in 2.5% methylcellulose/0.02% 3-aminobenzoic acid methyl ester (Sigma-Aldrich). Stained whole-mount embryos were photographed in 100% glycerol under a Leica MZ FLIII dissecting microscope with a Zeiss AxioCam. Confocal images of hearts from 3 dpf TG(fli1:EGFP) Y1 and MO2-treated 3 dpf TG(fli1:EGFP) Y1 embryos (n = 3 each) embedded in 1% low-melting agarose were taken with a Zeiss LSM 510 Meta upright confocal microscope using an Achroplan 403/0.8 W objective. Three-dimensional pictures were constructed with Imaris 3.1 software (Bitplane AG).
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